Dr. Mansour Haeryfar obtained his Doctorate in Laboratory
Medicine from the National University of Tehran, his M.Sc. from the University
of Manitoba (Winnipeg, Canada), and his Ph.D. from Dalhousie University
(Halifax, Canada). For his postdoctoral studies, he trained at the National
Institutes of Health (NIH) in Bethesda, Maryland, USA. He was recruited by
Western University in 2006 where he currently works as a Full Professor of
Immunology. Dr. Haeryfar’s team investigates mainstream and innate-like T-cell
responses to cancer and microbial pathogens with the ultimate goal of inventing
or optimizing novel T-cell-based therapies for several malignancies, infectious
diseases, and sepsis. Dr. Haeryfar’s studies have been supported by the
Canadian Institutes of Health Research (CIHR), Natural Sciences and Engineering
Research Council of Canada (NSERC), Canadian Cancer Society, Cancer Research
Society Inc., and Prostate Cancer Canada (PCC), among others. Dr. Haeryfar has
received several prestigious awards, including a Fogarty International
Fellowship award from NIH, an Ontario Ministry of Research and Innovation Early
Researcher Award, a Leaders Opportunity Fund from the Canada Foundation for
Innovation, a Canada Research Chair award (in Viral Immunity and Pathogenesis)
from the Government of Canada, and a Careers in Immunology Fellowship from the
American Association of Immunologists (AAI). At present, Dr. Haeryfar serves as
the President of the Canadian Society for Immunology.
Dr. Mansour Haeryfar obtained his Doctorate in Laboratory
Medicine from the National University of Tehran, his M.Sc. from the University
of Manitoba (Winnipeg, Canada), and his Ph.D. from Dalhousie University
(Halifax, Canada). For his postdoctoral studies, he trained at the National
Institutes of Health (NIH) in Bethesda, Maryland, USA. He was recruited by
Western University in 2006 where he currently works as a Full Professor of
Immunology. Dr. Haeryfar’s team investigates mainstream and innate-like T-cell
responses to cancer and microbial pathogens with the ultimate goal of inventing
or optimizing novel T-cell-based therapies for several malignancies, infectious
diseases, and sepsis. Dr. Haeryfar’s studies have been supported by the
Canadian Institutes of Health Research (CIHR), Natural Sciences and Engineering
Research Council of Canada (NSERC), Canadian Cancer Society, Cancer Research
Society Inc., and Prostate Cancer Canada (PCC), among others. Dr. Haeryfar has
received several prestigious awards, including a Fogarty International
Fellowship award from NIH, an Ontario Ministry of Research and Innovation Early
Researcher Award, a Leaders Opportunity Fund from the Canada Foundation for
Innovation, a Canada Research Chair award (in Viral Immunity and Pathogenesis)
from the Government of Canada, and a Careers in Immunology Fellowship from the
American Association of Immunologists (AAI). At present, Dr. Haeryfar serves as
the President of the Canadian Society for Immunology.